People in the News: Paul Billings, Stephen Jones, Thomas Kean, Allan Bombard, Ross Levine, More | GenomeWeb

Paul Billings has joined Omicia as chief medical officer and will serve on the company's scientific advisory board. Billings was previously chief medical officer at Thermo Fisher's Life Technologies. Before that, he was founding and acting director and CSO at the Genomic Medicine Institute at El Camino Hospital. He was also previously President, CEO, and director of CELLective Dx, as well as senior vice president and senior geneticist at Laboratory Corporation of America. He is currently a director at Trovagene and CollabRx.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.